Acrodermatitis chronica atrophicans laboratory findings
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Template:ANahita Raviteja Guddeti, M.B.B.S. [2]
|
Acrodermatitis chronica atrophicans Microchapters |
|
Differentiating Acrodermatitis chronica atrophicans from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Acrodermatitis chronica atrophicans laboratory findings On the Web |
|
American Roentgen Ray Society Images of Acrodermatitis chronica atrophicans laboratory findings |
|
FDA on Acrodermatitis chronica atrophicans laboratory findings |
|
CDC on Acrodermatitis chronica atrophicans laboratory findings |
|
Acrodermatitis chronica atrophicans laboratory findings in the news |
|
Blogs on Acrodermatitis chronica atrophicans laboratory findings |
|
Risk calculators and risk factors for Acrodermatitis chronica atrophicans laboratory findings |
Overview
An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of acrodermatitis chronica atrophicans.
Laboratory Findings
- Physicians can use serologic and histologic examination to confirm the diagnosis of acrodermatitis chronica atrophicans.
- High anti-spirochetal antibody levels has been detected at indirect immunofluorescence and enzyme linked immunosorbent assay (ELISA).[1]
- Biopsy shows chronic inflammatory signs in chronic cases. Other histological finding are listed below: [2][1]
References
- ↑ 1.0 1.1 Asbrink E, Hovmark A, Olsson I (1986). "Clinical manifestations of acrodermatitis chronica atrophicans in 50 Swedish patients". Zentralbl Bakteriol Mikrobiol Hyg A. 263 (1–2): 253–61. doi:10.1016/s0176-6724(86)80128-6. PMID 3577484.
- ↑ Rosenlund S, Bækgaard N, Menné T (2011). "[Acrodermatitis chronica atrophicans can be difficult to diagnose]". Ugeskr. Laeg. (in Danish). 173 (50): 3272–3. PMID 22153213. Unknown parameter
|month=ignored (help)